Dermatology Times' Sunday Crossword: April 27, 2025

Welcome to Dermatology Times' Sunday Crossword, where dermatology knowledge meets fun! Each week, we curate a selection of words and terms pulled directly from the latest news in the dermatology world. Whether it's breakthrough treatments, new research findings, or emerging trends, this crossword serves as both a challenge and an opportunity to reinforce your expertise in the field.

This week, our crossword puzzle features atopic dermatitis (AD)- related words and terms inspired by our coverage of AD throughout the month of April.

Want to hear more pearls and expert insights on AD? Join us at the annual Revolutionizing Atopic Dermatitis Conference this June in Nashville, TN. Use code DT40 for 40% off your RAD 2025 registration.

Try out either our interactive crossword or a static/non-interactive version below.

Interactive Crossword

This crossword was created with CrosswordLabs.com.

Static/Non-Interactive Crossword

Across

2. Strategy for choosing the right AD therapy at the right time

4. Hydrogel studied in a phase 2b trial for mild to moderate AD

7. Brand of microbiome-friendly lotion for AD

9. Acronym for a conference offering deep dives into AD care

10. Commonly disrupted by night-time itching in patients with AD

11. Janus kinase inhibitor shown to relieve ad symptoms faster than dupilumab

12. Poly-l-lysine biovectors were combined with these for AD efficacy

13. Describes the psychosocial and physical weight of chronic AD

Down

1. Underlying process targeted by many AD therapies

3. Clinical term for the hallmark symptom of AD

5. Topical JAK inhibitor evaluated for use in children aged 2–11

6. Aryl hydrocarbon receptor agonist with lasting effects in AD

8. IL-4 receptor blocker commonly used in moderate to severe AD

For answers to this week's puzzle, check out next week's edition of the Dermatology Times Sunday Crossword.

Answers from our April 20, 2025 puzzle: [Across: 2 - BDD; 5 - SIND; 6 - keratosis; 8 - lichen; 9 - antagonist; Down: 1 - basal; 3 - dupilumab; 4 - vitiligo; 6 - Kwatra; 7 - GEP]